Total Payments
$21,792
2024 Payments
$2,885
Companies
83
Transactions
1,091
Medicare Patients
13,672
Medicare Billing
$13.3M
Payment Breakdown by Category
Food & Beverage$15,842 (72.7%)
Consulting$3,880 (17.8%)
Other$1,760 (8.1%)
Education$310.33 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,842 | 1,061 | 72.7% |
| Consulting Fee | $3,880 | 7 | 17.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $910.00 | 2 | 4.2% |
| Honoraria | $850.00 | 1 | 3.9% |
| Education | $310.33 | 20 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,630 | 115 | $0 (2024) |
| PFIZER INC. | $1,372 | 153 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,157 | 72 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $1,001 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $988.99 | 73 | $0 (2024) |
| Genentech USA, Inc. | $921.05 | 71 | $0 (2024) |
| Verastem, Inc. | $893.10 | 2 | $0 (2020) |
| ABBVIE INC. | $878.32 | 12 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $867.59 | 7 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $862.51 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,885 | 162 | AstraZeneca Pharmaceuticals LP ($349.43) |
| 2023 | $2,733 | 164 | Celgene Corporation ($219.63) |
| 2022 | $3,351 | 160 | Eagle Pharmaceuticals, Inc. ($850.00) |
| 2021 | $3,633 | 157 | Karyopharm Therapeutics Inc. ($781.73) |
| 2020 | $3,049 | 89 | Verastem, Inc. ($880.00) |
| 2019 | $2,265 | 131 | AbbVie, Inc. ($720.94) |
| 2018 | $1,389 | 104 | Novartis Pharmaceuticals Corporation ($264.00) |
| 2017 | $2,487 | 124 | Ipsen Biopharmaceuticals, Inc ($750.00) |
All Payment Transactions
1,091 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: Hematology/Oncology | ||||||
| 12/17/2024 | PFIZER INC. | XYNTHA (Biological), BENEFIX, HYMPAVZI | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: HEMATOLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Oncology | ||||||
| 12/16/2024 | PFIZER INC. | XYNTHA (Biological), BENEFIX, HYMPAVZI | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: HEMATOLOGY | ||||||
| 12/13/2024 | Genentech USA, Inc. | Tecentriq (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: BioOncology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Oncology | ||||||
| 12/06/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Oncology | ||||||
| 11/25/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Oncology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Hematology | ||||||
| 11/11/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: DESMOID TUMORS | ||||||
| 11/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 59 | 3,867 | 380,597 | $16.0M | $4.4M |
| 2022 | 53 | 3,296 | 253,521 | $8.6M | $3.3M |
| 2021 | 60 | 3,172 | 340,201 | $7.9M | $2.6M |
| 2020 | 63 | 3,337 | 299,766 | $9.0M | $2.9M |
Total Patients
13,672
Total Services
1,274,085
Medicare Billing
$13.3M
Procedure Codes
235
All Medicare Procedures & Services
235 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 35 | 40,600 | $4.5M | $1.8M | 39.1% |
| J9299 | Injection, nivolumab, 1 mg | Office | 2023 | 12 | 32,480 | $2.0M | $768,915 | 38.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 38 | 18,360 | $868,320 | $339,776 | 39.1% |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Office | 2023 | 12 | 23,000 | $734,600 | $227,965 | 31.0% |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | Office | 2023 | 103 | 44,600 | $689,000 | $205,929 | 29.9% |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | Office | 2023 | 21 | 4,950 | $881,760 | $169,831 | 19.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 209 | 1,531 | $705,888 | $143,863 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 334 | 1,168 | $227,053 | $106,876 | 47.1% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 12 | 1,610 | $360,540 | $101,709 | 28.2% |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | Office | 2023 | 21 | 900 | $656,268 | $89,352 | 13.6% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 106 | 61,880 | $418,834 | $84,607 | 20.2% |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | Office | 2023 | 12 | 3,432 | $315,744 | $84,514 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 579 | 827 | $100,304 | $48,391 | 48.2% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 25 | 36,750 | $152,250 | $32,258 | 21.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 161 | 1,402 | $171,363 | $29,757 | 17.4% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 36 | 212 | $139,072 | $24,711 | 17.8% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 80 | 398 | $100,534 | $18,503 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $46,482 | $17,976 | 38.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 109 | 771 | $112,996 | $15,918 | 14.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 105 | $214,221 | $14,197 | 6.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 138 | 1,256 | $95,007 | $14,144 | 14.9% |
| J9395 | Injection, fulvestrant, 25 mg | Office | 2023 | 13 | 1,700 | $385,340 | $13,261 | 3.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 159 | 1,010 | $70,938 | $10,519 | 14.8% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2023 | 56 | 245 | $51,291 | $9,781 | 19.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $24,028 | $9,776 | 40.7% |
About Dr. Travis Koeneke, MD
Dr. Travis Koeneke, MD is a Internal Medicine healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942305677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Travis Koeneke, MD has received a total of $21,792 in payments from pharmaceutical and medical device companies, with $2,885 received in 2024. These payments were reported across 1,091 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($15,842).
As a Medicare-enrolled provider, Koeneke has provided services to 13,672 Medicare beneficiaries, totaling 1,274,085 services with total Medicare billing of $13.3M. Data is available for 4 years (2020–2023), covering 235 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Manhattan, KS
- Active Since 09/14/2006
- Last Updated 03/22/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942305677
Products in Payments
- Tavalisse (Drug) $952.64
- Copiktra (Drug) $893.10
- XPOVIO (Drug) $862.51
- PEMFEXY (Drug) $850.00
- Onivyde (Drug) $794.76
- KEYTRUDA (Biological) $790.40
- OPDIVO (Biological) $612.36
- Trelstar (Drug) $500.00
- KISQALI (Drug) $408.64
- IBRANCE (Drug) $336.03
- XTANDI (Drug) $334.94
- LYNPARZA (Drug) $272.06
- MEKINIST (Drug) $255.71
- VERZENIO (Drug) $248.75
- IMBRUVICA (Drug) $236.08
- REBLOZYL (Biological) $229.81
- Enhertu (Drug) $229.75
- JAKAFI (Drug) $221.42
- PROMACTA (Drug) $220.88
- ERLEADA (Drug) $210.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Manhattan
Preeti Singh, Md, MD
Internal Medicine — Payments: $1,367
Internal Medicine $1,367
Roger Peck, Md, MD
Internal Medicine — Payments: $969.45
Internal Medicine $969.45
Mrs. Segen Elizabeth Chase, M.d, M.D
Internal Medicine — Payments: $712.51
Internal Medicine $712.51
Matthew Floersch, M.d, M.D
Internal Medicine — Payments: $587.18
Internal Medicine $587.18
Kenna Fischman, Md, MD
Internal Medicine — Payments: $572.14
Internal Medicine $572.14
Sara Stewart, Md, MD
Internal Medicine — Payments: $512.01
Internal Medicine $512.01